|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 381.8 SEK | +2.47% |
|
+1.27% | +32.85% |
| Apr. 25 | Mycronic AB has Received Replacement Order for A Prexision 80 Evo from an Existing Customer in Asia | CI |
| Apr. 18 | Transcript : Mycronic AB, Q1 2024 Earnings Call, Apr 18, 2024 |
Mycronic AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 5,706 million compared to SEK 5,119 million a year ago. Net income was SEK 998 million compared to SEK 741 million a year ago.
Basic earnings per share from continuing operations was SEK 10.22 compared to SEK 7.59 a year ago. Diluted earnings per share from continuing operations was SEK 10.22 compared to SEK 7.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +32.85% | 3.4B | |
| +18.14% | 121B | |
| +35.54% | 101B | |
| +10.67% | 19.99B | |
| +5.56% | 18.83B | |
| +35.96% | 9.77B | |
| +24.11% | 9.34B | |
| -7.97% | 7.54B | |
| -23.57% | 6.08B | |
| +36.78% | 5.4B |
MYCRONIC AB 
